Lisa Malincarne
Overview
Explore the profile of Lisa Malincarne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tordi S, Gonnelli G, Benvenuto M, Rosignoli D, Malincarne L, Francisci D
Infect Dis Rep
. 2024 Dec;
16(6):1254-1262.
PMID: 39728021
Background: The 2023 European Society of Cardiology (ESC) guidelines for the management of infective endocarditis (IE) highlighted the essential role of multimodal imaging in the diagnostic algorithm of IE and...
2.
Schiaroli E, Gidari A, Brachelente G, Bicchieraro G, Spaccapelo R, Bastianelli S, et al.
J Clin Virol
. 2023 Oct;
168:105584.
PMID: 37778220
Background: Tixagevimab-cilgavimab has been approved as primary pre-exposure prophylaxis in immunocompromised patients as support or replacement for vaccination, even though the Omicron variant of concern (VOC) was spreading at the...
3.
Schiaroli E, De Socio G, Gidari A, Malincarne L, Benedetti S, Lanzi A, et al.
Mediterr J Hematol Infect Dis
. 2022 Jul;
14(1):e2022050.
PMID: 35865399
Background And Objective: In patients with mild-to-moderate COVID-19 and at high risk of progression, casirivimab/imdevimab and bamlanivimab/etesivimab were utilized in Umbria from late April to November 2021. This period was...
4.
Schiaroli E, De Socio G, Martinelli L, Malincarne L, Savoia M, Spinelli A, et al.
Mediterr J Hematol Infect Dis
. 2021 Nov;
13(1):e2021061.
PMID: 34804435
Background And Objective: The use of monoclonal antibodies to the SARS-Cov-2 spike protein for early treatment of COVID-19 disease is being evaluated, with only phase 2 studies available to date....
5.
Pasticci M, Papalini C, Murgia N, Papili R, Bucaneve G, Malincarne L, et al.
Infez Med
. 2021 Jun;
29(2):229-235.
PMID: 34061788
Interferon-γ releasing assays (IGRAs) are currently widely employed in the initial work up of Mycobacterium tuberculosis infection, as well as in suspected tuberculosis (TB). These assays are commonly utilized over...
6.
De Socio G, Malincarne L, Arena S, Troiani S, Benedetti S, Camilloni B, et al.
Mediterr J Hematol Infect Dis
. 2020 May;
12(1):e2020033.
PMID: 32395222
No abstract available.
7.
Malincarne L, Schiaroli E, Ciervo A, Scaglione V, Paciaroni M, Mancini F, et al.
Int J Infect Dis
. 2019 Mar;
82:30-32.
PMID: 30818047
Borrelia crocidurae is endemic in West Africa, where it represents the leading cause of tick-borne relapsing fever (TBRF). TBRF typically presents with high fever and systemic symptoms, followed by recurrent...
8.
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients
Falcinelli E, Francisci D, Schiaroli E, Minuz P, Orsini S, Malincarne L, et al.
Int J Cardiol
. 2018 Apr;
263:118-124.
PMID: 29685693
Background: Ischemic cardiovascular events are a relevant cause of morbidity and mortality in HIV-infected patients. Use of abacavir (ABC), a nucleoside analog reverse transcriptase inhibitor, has been associated with increased...
9.
Gabrielli C, Cardaci S, Malincarne L, Pasticci M
SAGE Open Med Case Rep
. 2018 Apr;
6:2050313X18767229.
PMID: 29623206
A 37-year-old Caucasian male, HIV-infected (CDC A2) in 2012 and on antiretroviral therapy, presented for a follow-up visit. On physical examination, a barely discernible light-colored macular rash was observed on...
10.
Pallotto C, Martinelli L, Baldelli F, Bucaneve G, Cecchini E, Malincarne L, et al.
Infez Med
. 2014 Jun;
22(2):124-31.
PMID: 24955799
The aim of this study was to evaluate the epidemiological and clinical characteristics of 232 cases of infective endocarditis (IE), admitted to the Clinica delle Malattie Infettive of Perugia Italy...